为探究 BCMA 靶向疗法治疗多发性骨髓瘤（MM）的效果，研究人员总结 2024 ASH 年会成果，为患者带来希望。 在血液疾病的领域中，多发性骨髓瘤（Multiple Myeloma，MM）一直是困扰医学界的难题。这是一种恶性浆细胞病，随着病情发展，患者的正常造血功能受到抑制 ...

BMS, says Kaiser, is tripling down on BCMA across different modalities. Multiple avenues for therapy Among these novel modalities, chimeric antigen receptor (CAR) T cells have the longest history ...

Although chimeric antigen receptor T-cell therapy has raised hopes for long-term remission in autoimmune disease, it has ...

Chimeric antigen receptor (CAR) T-cell therapy has had a ... Newer approved agents target B-cell maturation antigen (BCMA), ...